A retrospective feasibility study reports that a deep learning network substantially improved simulated ultra-low-dose ...
BioArctic AB's (publ) (NASDAQ Stockholm: BIOA B) partner Eisai today published the preliminary global revenue for Leqembi for the third quarter 2026, in conjunction with their partner Biogen's third ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results